Litcius/Paper detail

Outcome predictors in COVID-19: An analysis of emergent systemic inflammation indices in Mexican population

Ilse Adriana Gutiérrez-Pérez, Ivette Buendía-Roldán, Gloría Pérez-Rubio, Leslie Chávez‐Galán, Rafael de Jesús Hernández-Zenteno, Hiram Aguilar‐Duran, Ingrid Fricke-Galindo, Óscar Zaragoza-García, Ramcés Falfán‐Valencia, Iris Paola Guzmán‐Guzmán

2022Frontiers in Medicine27 citationsDOIOpen Access PDF

Abstract

Introduction The systemic viral disease caused by the SARS-CoV-2 called coronavirus disease 2019 (COVID-19) continues to be a public health problem worldwide. Objective This study is aimed to evaluate the association and predictive value of indices of systemic inflammation with severity and non-survival of COVID-19 in Mexican patients. Materials and Methods A retrospective study was carried out on 807 subjects with a confirmed diagnosis of COVID-19. Clinical characteristics, acute respiratory distress syndrome (ARDS), severity according to PaO 2 /FiO 2 ratio, invasive mechanical ventilation (IMV), and non-survival outcome were considered to assess the predictive value and the association of 11 systemic inflammatory indices derived from hematological parameters analyzed at the hospital admission of patients. The receiver operating characteristics curve was applied to determine the thresholds for 11 biomarkers, and their prognostic values were assessed via the Kaplan-Meier method. Results 26% of the studied subjects showed COVID-19 severe (PaO 2 /FiO 2 ratio ≤ 100), 82.4% required IMV, and 39.2% were non-survival. The indices NHL, NLR, RDW, dNLR, and SIRI displayed predictive values for severe COVID-19 and non-survival. NHL, SIRI, and NLR showed predictive value for IMV. The cut-off values for RDW (OR = 1.85, p < 0.001), NHL (OR = 1.67, p = 0.004) and NLR (OR = 1.56, p = 0.012) were mainly associated with severe COVID-19. NHL (OR = 3.07, p < 0.001), AISI (OR = 2.64, p < 0.001) and SIRI (OR = 2.51, p < 0.001) were associated with IMV support, while for non-survival the main indices associated were NHL (OR = 2.65, p < 0.001), NLR (OR = 2.26, p < 0.001), dNLR (OR = 1.92, p < 0.001), SIRI (OR = 1.67, p = 0.002) and SII (OR = 1.50, p = 0.010). The patients with an RDW, PLR, NLR, dNLR, MLR, SII, and NHL above the cut-off had a survival probability of COVID-19 50% lower, with an estimated mean survival time of 40 days. Conclusion The emergent systemic inflammation indices NHL, NLR, RDW, SII, and SIRI have a predictive power of severe COVID-19, IMV support, and low survival probability during hospitalization by COVID-19 in Mexican patients.

Topics & Concepts

MedicineARDSInternal medicineSystemic inflammationMechanical ventilationRetrospective cohort studyCoronavirus disease 2019 (COVID-19)PopulationPredictive valueAcute respiratory distressReceiver operating characteristicSystemic inflammatory response syndromeSeverity of illnessSurvival analysisGastroenterologyDiseaseInflammationLungSepsisInfectious disease (medical specialty)Environmental healthCOVID-19 Clinical Research StudiesInflammasome and immune disordersInflammatory Biomarkers in Disease Prognosis